RxSight, Inc. (RXST)

8.71 -0.23 (-2.57%) USD  |  NASDAQ  |  Feb 25, 12:35
More

RxSight Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for RXST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Abbott Laboratories --
Accuray, Inc. Upgrade
Alphatec Holdings, Inc. Upgrade
Boston Scientific Corp. Upgrade
Plus Therapeutics, Inc. Upgrade